Figure 1From: Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in ZanzibarSNP frequencies in Zanzibar before (2002–2003) and seven years after (2010) ASAQ implementation. Asterisk (*) and (**) indicate statistically significant differences of p < 0.05 and p < 0.001, respectively.Back to article page